B-cell imaging with zirconium-89 labelled rituximab PET-CT at baseline is associated with therapeutic response 24 weeks after initiation of rituximab treatment in rheumatoid arthritis patients

BACKGROUND: B cells are key players in the pathogenesis of rheumatoid arthritis (RA). Although successful in 50–60% of patients with RA, anti-B-cell therapy given as rituximab could be more efficient by identifying potential responders prior to treatment. Positron emission tomography (PET) using rad...

全面介紹

Na minha lista:
書目詳細資料
發表在:Arthritis Res Ther
Main Authors: Bruijnen, Stefan, Tsang-A-Sjoe, Michel, Raterman, Hennie, Ramwadhdoebe, Tamara, Vugts, Daniëlle, van Dongen, Guus, Huisman, Marc, Hoekstra, Otto, Tak, Paul-Peter, Voskuyl, Alexandre, van der Laken, Conny
格式: Artigo
語言:Inglês
出版: BioMed Central 2016
主題:
Research Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5116204/
https://ncbi.nlm.nih.gov/pubmed/27863504
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-016-1166-z
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍